14 results
424B4
CNSP
Cns Pharmaceuticals Inc
31 Jan 24
Prospectus supplement with pricing info
4:27pm
pharmaceutical product safety and effectiveness and may require testing and surveillance programs to monitor the safety of approved products that have
10-K
ai4mv41b0
12 Mar 20
Annual report
4:06pm
424B4
cb6 tdkwmh
8 Nov 19
Prospectus supplement with pricing info
4:25pm
S-1/A
z2x2 0o4y6f
16 Jul 19
IPO registration (amended)
1:23pm
S-1
e8mtz0ksksewhoyzxpwg
28 Jun 19
IPO registration
5:04pm
DRS
kca1bi
28 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next